These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6226856)

  • 81. Phase II study of chlorozotocin in leukemia and other hematologic malignancies.
    Pavlovsky S; Woolley PV; Garay G; Scaglione C; Hoth D; Schein PS
    Cancer Treat Rep; 1981; 65(11-12):1109-11. PubMed ID: 6457686
    [No Abstract]   [Full Text] [Related]  

  • 82. Phase II study of 5-FU, doxorubicin, and mitomycin (FAM) and chlorozotocin in advanced measureable pancreatic cancer.
    Smith FP; Rustgi VK; Schertz G; Woolley PV; Schein PS
    Cancer Treat Rep; 1982 Dec; 66(12):2095-6. PubMed ID: 6215982
    [No Abstract]   [Full Text] [Related]  

  • 83. A phase I, II study of high-dose 5-fluorouracil and high-dose leucovorin with low-dose phosphonacetyl-L-aspartic acid in patients with advanced malignancies.
    Ardalan B; Sridhar KS; Benedetto P; Richman S; Waldman S; Morrell L; Feun L; Savaraj N; Fodor M; Livingstone A
    Cancer; 1991 Sep; 68(6):1242-6. PubMed ID: 1873776
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Weekly levofolinic acid and 5-fluorouracil plus hydroxyurea in metastatic gastrointestinal adenocarcinomas.
    Gebbia V; Valenza R; Testa A; Cipolla C; Latteri M; Curto G; Comande S; Buccellato C; Gebbia N
    Am J Clin Oncol; 1994 Dec; 17(6):485-9. PubMed ID: 7977165
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Sequential morphologic analysis of the nephrotoxicity produced in rats by single doses of chlorozotocin.
    Dees JH; Kramer RA
    Toxicol Pathol; 1986; 14(2):213-31. PubMed ID: 2945250
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clinical management of advanced gastrointestinal cancer.
    Moertel CG
    Cancer; 1975 Aug; 36(2):675-82. PubMed ID: 168961
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [New developments in chemotherapy of gastrointestinal carcinomas].
    Hartung G
    Onkologie; 2001 Sep; 24 Suppl 5():10-5. PubMed ID: 11600807
    [No Abstract]   [Full Text] [Related]  

  • 88. Antitumor activity of a nitrosourea derivative, CNUA, on murine tumors.
    Edanami K; Komiyama K; Kuroda T; Umezawa I
    Cancer Chemother Pharmacol; 1984; 13(1):22-6. PubMed ID: 6234104
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Outpatient chemotherapy with weekly high-dose infusional 5-fluorouracil (weekly HD-FU) in advanced gastrointestinal cancer].
    Tsuji Y; Kuroiwa G; Kato M; Ohi M; Handa H; Honjo K; Uehara S; Hirayama A
    Gan To Kagaku Ryoho; 1998 Dec; 25 Suppl 4():619-24. PubMed ID: 9884653
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Clinical evaluation strategy in specific disease types - clinical study of gastrointestinal cancer chemotherapy in one institute of Japan.
    Saito T
    Recent Results Cancer Res; 1980; 70():187-202. PubMed ID: 6986642
    [No Abstract]   [Full Text] [Related]  

  • 91. Molecular markers predictive of response to chemotherapy in gastrointestinal tumors.
    Catalano V; Baldelli AM; Giordani P; Cascinu S
    Crit Rev Oncol Hematol; 2001 May; 38(2):93-104. PubMed ID: 11311657
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Chemoradiotherapy for gastrointestinal cancers.
    Rich TA; Crane C; Lawson JD; Landry J
    Curr Oncol Rep; 2005 May; 7(3):196-202. PubMed ID: 15847710
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Chlorozotocin.
    IARC Monogr Eval Carcinog Risks Hum; 1990; 50():65-75. PubMed ID: 2149865
    [No Abstract]   [Full Text] [Related]  

  • 94. What is the real value of metronomic chemotherapy in the treatment of gastrointestinal cancer?
    El Darsa H; El Sayed R; Abdel-Rahman O
    Expert Opin Pharmacother; 2021 Dec; 22(17):2297-2302. PubMed ID: 34165012
    [No Abstract]   [Full Text] [Related]  

  • 95. ESMO World Congress on Gastrointestinal Cancer 2021.
    Gourd K
    Lancet Oncol; 2021 Aug; 22(8):1062. PubMed ID: 34246329
    [No Abstract]   [Full Text] [Related]  

  • 96. Chlorozotocin treatment of advanced gastrointestinal cancer.
    Veronesi A; Magri MD; Tirelli U; Galligioni E; Figoli F; Zagonel V; Tumolo S; Grigoletto E
    Med Pediatr Oncol; 1983; 11(5):365-6. PubMed ID: 6226856
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Phase II study of chlorozotocin in the treatment of advanced colorectal cancer.
    Lawton JO; Giles GR; Hall J; MacAdam A; Hall R; Matheson T; Bird G
    Cancer Treat Rep; 1981; 65(1-2):13-15. PubMed ID: 6452945
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.
    Moertel CG; Lefkopoulo M; Lipsitz S; Hahn RG; Klaassen D
    N Engl J Med; 1992 Feb; 326(8):519-23. PubMed ID: 1310159
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Phase I trial of chlorozotocin.
    Gralla RJ; Tan CT; Young CW
    Cancer Treat Rep; 1979 Jan; 63(1):17-20. PubMed ID: 154363
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Contributions of nitrosoureas to cancer treatment.
    Mitchell EP; Schein PS
    Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.